Pomalidomide

Sold as Imnovid, Pomylo, Pomalidomide forrester, Pomalidomide cipla, Pomaxel, Pomarza, Ampomy

C₁₃H₁₁N₃O₄273.24 g/mol

4-Amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione

Drag to rotate. Structure from PubChem CID 134780.

Loading Wikipedia summary

Registration

Applicants: 6
Registrations: 28
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Key Oncologics (Pty) Ltd	Imnovid	1mg, 2 mg, 3 mg, 4mg	490744, 490745, 490746, 490747	S4	None
Forrester Pharma (Pty) Ltd	Pomylo, Pomalidomide forrester	1 mg, 2 mg, 3 mg, 4 mg	560189, 560190, 560191, 560192, 560193.189, 560194.190, 560195.191, 560196.192	S4	None
Cipla Medpro (Pty) Ltd	Pomalidomide cipla	1 mg, 2 mg, 3 mg, 4 mg	560540, 560541, 560542, 560543	S4	None
Eurolab (Pty) Ltd	Pomaxel	1 mg, 2 mg, 3 mg, 4 mg	560721, 560722, 560723, 560724	S4	None
Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr Reddy's Laboratories (Pty) Ltd	Pomarza	1, 2, 3, 4	590092, 590093, 590094, 590095	S4	PI PIL
Hetero Drugs South Africa (Pty) Ltd	Ampomy	1 mg, 2 mg, 3 mg, 4 mg	590309, 590310, 590311, 590312	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Imnovid 1mg EACH CAPSULE CONTAINS: POMALIDOMIDE 1,0 mg	1mg	49074449/32.2/0744	Registered	S4	None
Imnovid 2 MG EACH CAPSULE CONTAINS: POMALIDOMIDE 2,0 mg	2 mg	49074549/32.2/0745	Registered	S4	None
Imnovid 3 MG EACH CAPSULE CONTAINS: POMALIDOMIDE 3,0 mg	3 mg	49074649/32.2/0746	Registered	S4	None
Imnovid 4mg EACH CAPSULE CONTAINS: POMALIDOMIDE 4,0 mg	4mg	49074749/32.2/0747	Registered	S4	None
Pomylo 1 MG EACH CAPSULE CONTAINS POMALIDOMIDE 1,0 mg	1 mg	56018956/32.2/0189	Registered	S4	None
Pomylo 2 MG EACH CAPSULE CONTAINS POMALIDOMIDE 2,0 mg	2 mg	56019056/32.2/0190	Registered	S4	None
Pomylo 3 MG EACH CAPSULE CONTAINS POMALIDOMIDE 3,0 mg	3 mg	56019156/32.2/0191	Registered	S4	None
Pomylo 4 MG EACH CAPSULE CONTAINS POMALIDOMIDE 4,0 mg	4 mg	56019256/32.2/0192	Registered	S4	None
Pomalidomide 1 MG forrester EACH CAPSULE CONTAINS POMALIDOMIDE 1,0 mg	1 mg	560193.18956/32.2/0193.189	Registered	S4	None
Pomalidomide 2 MG forrester EACH CAPSULE CONTAINS POMALIDOMIDE 2,0 mg	2 mg	560194.19056/32.2/0194.190	Registered	S4	None
Pomalidomide 3 MG forrester EACH CAPSULE CONTAINS POMALIDOMIDE 3,0 mg	3 mg	560195.19156/32.2/0195.191	Registered	S4	None
Pomalidomide 4 MG forrester EACH CAPSULE CONTAINS POMALIDOMIDE 4,0 mg	4 mg	560196.19256/32.2/0196.192	Registered	S4	None
Pomalidomide 1 MG cipla EACH CAPSULE CONTAINS POMALIDOMIDE 1,0 mg	1 mg	56054056/32/0540	Registered	S4	None
Pomalidomide 2 MG cipla EACH CAPSULE CONTAINS POMALIDOMIDE 2,0 mg	2 mg	56054156/32/0541	Registered	S4	None
Pomalidomide 3 MG cipla EACH CAPSULE CONTAINS POMALIDOMIDE 3,0 mg	3 mg	56054256/32/0542	Registered	S4	None
Pomalidomide 4 MG cipla EACH CAPSULE CONTAINS POMALIDOMIDE 4,0 mg	4 mg	56054356/32/0543	Registered	S4	None
Pomaxel 1 MG EACH CAPSULE CONTAINS POMALIDOMIDE 1,0 mg	1 mg	56072156/32/0721	Registered	S4	None
Pomaxel 2 MG EACH CAPSULE CONTAINS POMALIDOMIDE 2,0 mg	2 mg	56072256/32/0722	Registered	S4	None
Pomaxel 3 MG EACH CAPSULE CONTAINS POMALIDOMIDE 3,0 mg	3 mg	56072356/32/0723	Registered	S4	None
Pomaxel 4 MG EACH CAPSULE CONTAINS POMALIDOMIDE 4,0 mg	4 mg	56072456/32/0724	Registered	S4	None
Pomarza 1 EACH CAPSULE CONTAINS: POMALIDOMIDE 1,0 mg	1Gelatin capsules	59009259/32/0092Approved 3 February 2026	Registered	S4	PI PIL
Pomarza 2 EACH CAPSULE CONTAINS: POMALIDOMIDE 2,0 mg	2Gelatin capsules	59009359/32/0093Approved 3 February 2026	Registered	S4	PI PIL
Pomarza 3 EACH CAPSULE CONTAINS: POMALIDOMIDE 3,0 mg	3Gelatin capsules	59009459/32/0094Approved 3 February 2026	Registered	S4	PI PIL
Pomarza 4 EACH CAPSULE CONTAINS: POMALIDOMIDE 4,0 mg	4Gelatin capsules	59009559/32/0095Approved 3 February 2026	Registered	S4	PI PIL
Ampomy 1 MG EACH CAPSULE CONTAINS: POMALIDOMIDE 1,0 mg	1 mg	59030959/32.16/0309	Registered	S4	None
Ampomy 2 MG EACH CAPSULE CONTAINS: POMALIDOMIDE 2,0 mg	2 mg	59031059/32.16/0310	Registered	S4	None
Ampomy 3 MG EACH CAPSULE CONTAINS: POMALIDOMIDE 3,0 mg	3 mg	59031159/32.16/0311	Registered	S4	None
Ampomy 4 MG EACH CAPSULE CONTAINS: POMALIDOMIDE 4,0 mg	4 mg	59031259/32.16/0312	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Pomalidomide

S4: Pomalidomide
Consolidated Schedules 06 July 2026, line 7609

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Pomarza 1, Dr Reddyæs Laboratories (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsPomarza 1, Dr Reddyæs Laboratories (Pty) Ltd Patient information leaflet (PIL)For patients and carersPomarza 1, Dr Reddyæs Laboratories (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background